With $190M in in­vestor cash to play with, Chi­na's Chime Bi­o­log­ics looks to build 15x man­u­fac­tur­ing ca­pac­i­ty by 2024

One year af­ter es­tab­lish­ing it­self as a stand-alone CD­MO, Chime Bi­o­log­ics will start the sec­ond phase of a fa­cil­i­ty ex­pan­sion that plans to in­crease its man­u­fac­tur­ing ca­pac­i­ty to more than 140,000 liters with­in the next five years.

The news comes af­ter the com­pa­ny an­nounced Thurs­day that it closed an ex­pand­ed $190 mil­lion Se­ries A round.

“We will con­tin­u­ous­ly build up ad­vanced tech­nol­o­gy plat­forms and more ca­pac­i­ties to bet­ter serve our cus­tomers, and al­so wel­come bi­o­log­ics part­ners from all over the world to come here, ex­chang­ing ex­pe­ri­ences and seek­ing for de­vel­op­ments to­geth­er,” CEO Xi­an­fang “John” Zeng said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER